Subscribe Now
 Already a subscriber? Log-in!
By subscribing to Laboratory Industry Report, each month you'll get an insider's view of the lab industry's most important business and financial trends, plus predictions for the coming year.
In each issue, you find:
- Comparative data on lab pricing
- Information and explanations describing how to deal with healthcare integration, capitation, technology advances, etc.
- Clear perspectives of how your firm is performing vs. the market at large How publicly-traded lab companies are performing and what their top executives earn
- Updates on late-breaking mergers & acquisitions.
Are you up on what's working—and what's not—for laboratories located in a variety of practice settings-hospital, commercial, group practice sites and network systems?
More importantly, do you know where to turn for business intelligence & insight when you need to know what's happening to key companies, how Wall Street views the industry, or the latest scoop on mergers, buyouts, consolidations and alliances?
Laboratory Industry Report is a must for everyone having a vital stake in today's competitive lab marketplace-owner, director, pathologist, CEO, COO, CFO, general manager, administrator, manager, marketeer, or vendor.
With Laboratory Industry Report, you'll get all the business news & insights which are accurate, objective, reliable, and authoritative. Gain a competitive edge for your company or institution today by subscribing today!
|
|
|
 |
 | LIR December 2007 (full PDF issue) |
| TOP OF THE NEWS
San Diego labs prepare for competitive bidding demo
Quest to launch lab in India
COUNTERPOINT
Time is right for bidding demo
REGULATORY NEWS
’08 fee schedule ends pod labs
INSIDE THE LAB INDUSTRY
Molecular lab growing in unexpected ways
JOINT VENTURES
PAML, MountainStar team up
CONTRACTS
United, Georgia Diagnostic Clinic end dispute
FINANCIAL
Lab stocks take November dip
INDUSTRY BUZZ
Canada’s MDS is now LifeLabs
Full Article |
| Quest Confirms Launch of India Operations |
| Citing the potential to serve an area of rapid population growth, Quest Diagnostics is currently building a lab in India’s New Delhi region and expects to have the business up and running in 2008. The laboratory company also appointed Janak Singh Bajwa as managing director of Quest Diagnostics Pvt. Ltd.
Full Article |
| San Diego Labs Prepare for Competitive Bidding Demo |
| The first question on many minds of San Diego County laboratorians is why the Centers for Medicare & Medicaid Services (CMS) chose this region as the first of two sites for the competitive bidding demonstration project. In selecting a site or Metropolitan Statistical Area (MSA), CMS wanted to have enough labs for effective bidding and multiple winners, as well as a patient population that reflected the national laboratory market. But this is not the case in San Diego, explained Donna Serpico-Thompson, the vice president of business development for Sharp HealthCare, an area healthcare system that includes four hospital outreach laboratories, as well as eight independent labs.
Full Article |
| Counterpoint: Time Is Right for Competitive Bidding Demo |
| While most of the clinical lab industry have denounced CMS’s competitive bidding demonstration project as a misguided attempt to lower reimbursement prices for testing services, some are supporting the initiative, stating that it’s an appropriate approach to reign in healthcare spending and put Medicare prices in line with those of private payors.
Full Article |
| 2008 Fee Schedule Ends Pod Labs |
| CMS is cracking down on pod labs through a new anti-markup provision in the 2008 Final Physician Fee Schedule. The rule takes away any financial incentive for physician groups to set up pod labs to profit from anatomic pathology work, explained Donna Meyer, assistant director of professional affairs for the College of American Pathologists (CAP).
Full Article |
| Spokane’s Sacred Heart Molecular Lab Growing in Unexpected Ways |
| For 2007, Washington G-2 Reports values molecular diagnostic testing at $4.1 billion and estimates growth of approximately 19% each year through 2010. Last year, estimates for the U.S. market for molecular diagnostic testing totaled $3.5 billion, with infectious disease testing accounting for about half of that amount and the remainder comprising blood screening and genetic testing.
Full Article |
| United, Georgia Diagnostic Clinic End Contract Disputes |
| Months of tense negotiations with United HealthCare has finally resulted in a new contract between one of the nation’s largest health insurance providers and the Northeast Georgia Diagnostic Clinic, located northeast of Atlanta.
Full Article |
| Lab Stocks Take a 7% Dip in November |
| The G-2 Laboratory Stock Index is reflecting the current turbulence on Wall Street, with lab stocks down 7% over the five weeks ended November 16. So far this year, the index is up 13%, while the Nasdaq and S&P 500 continue to make small gains; the Nasdaq is up over 9% and the S&P is up almost 3% over the end of 2006.
Full Article |
| Canada’s MDS Is Now LifeLabs |
| As a result of a recent corporate sale, MDS Diagnostics has been renamed LifeLabs. In February 2007, MDS was sold to Borealis Infrastructure, an investment entity of OMERS (Ontario Municipal Employees Retirement System), for CAD$1.33 billion. The laboratory company was formerly owned by MDS Inc., a Toronto-based international life sciences company.
Full Article |
|
|
Please choose an archived issue to view newsletter table of contents above
|
|
